Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06632418 · ClinicalTrials.gov registry record · Phase 2
Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula Healing
A Phase 2 study of Anal Fistula and Complex Perianal Fistula, sponsored by Alexander Hawkins.
- Active
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06632418 is a Phase 2 study of Anal Fistula and Complex Perianal Fistula that is active but no longer recruiting, run by Alexander Hawkins. The registered enrollment target is 12 participants, below the 300-participant average among 5 other Anal Fistula trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06632418, a Phase 2 study of Anal Fistula and Complex Perianal Fistula, is active but no longer recruiting, sponsored by Alexander Hawkins.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The average success rate for healing and remission of complex perianal fistulas, idiopathic or Crohn's-related, is approximately 50%. These abnormal connections between the rectum and the outside skin remain a major clinical challenge in need of new treatments aimed at tissue repair. Platelet-derived growth factor drives wound healing and tissue regeneration, and manufactured PDGF is currently used to heal diabetic foot ulcers and regenerate bone in periodontal and orthopedic patients. Manufactured recombinant human PDGF has the potential to improve the success rate for complete healing of complex perianal fistulas, reduce the recurrence rate due to reopening of the fistula tract, and avoid complications associated with routine surgical interventions.
Conditions Studied
Interventions
- DRUG RhPDGF-BB
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-11-25 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06632418
The ClinicalTrials.gov registry entry for NCT06632418 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 300-participant average among 5 other Anal Fistula trials with a reported enrollment target (96% lower). The listed sponsor is Alexander Hawkins, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anal Fistula appearing as the primary indexed condition, and to 1 intervention - of which RhPDGF-BB is the first listed.
NCT06632418 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06632418 about?
NCT06632418 is a clinical study titled "Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula Healing". The average success rate for healing and remission of complex perianal fistulas, idiopathic or Crohn's-related, is approximately 50%. These abnormal connections between the rectum and the outside skin remain a major clinical challenge in need of new treatments aimed at tissue repair. Platelet-derive...
What is the current status of trial NCT06632418?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2024-11-25. Estimated completion is 2026-10.
What conditions does trial NCT06632418 study?
This clinical trial studies the following conditions: Anal Fistula, Complex Perianal Fistula.
What interventions are being tested in trial NCT06632418?
The interventions under investigation include: RhPDGF-BB (DRUG).
Who is sponsoring clinical trial NCT06632418?
This trial is sponsored by Alexander Hawkins, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06632418 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma
RECRUITING · NA
-
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
RECRUITING · Phase 1
-
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
RECRUITING · NA
-
Myriad™ Augmented Soft Tissue Reconstruction Registry
RECRUITING
-
Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.